384 related articles for article (PubMed ID: 20622270)
21. [The treatment of paroxysmal supraventricular arrhythmias in IHD patients with a high risk of developing complications from the anti-arrhythmic therapy].
Andriushchenko OM; Olesin AI
Ter Arkh; 1996; 68(5):57-60. PubMed ID: 9082603
[TBL] [Abstract][Full Text] [Related]
22. [Role of a "bystander" concealed accessory pathway in the response to verapamil and flecainide treatment in a patient with nodal reentry tachycardia].
Matteucci C; Busi G
G Ital Cardiol; 1996 Apr; 26(4):419-25. PubMed ID: 8707026
[TBL] [Abstract][Full Text] [Related]
23. [Propafenon, a new antiarrhythmic agent for the treatment of ectopic and rapid cardiac arrhythmias (author's transl)].
Beck OA
Med Klin; 1975 Jan; 70(3-2):95-101. PubMed ID: 48183
[TBL] [Abstract][Full Text] [Related]
24. [Use of propafenone in emergency therapy].
Liguori A; Pellegrino G; Di Ieso N; Piatto A; Ruggiero P; Scarnera P; Guardascione A
Clin Ter; 1989 Dec; 131(5):307-14. PubMed ID: 2532584
[TBL] [Abstract][Full Text] [Related]
25. [Amiodarone-induced hyperthyroidism causing progression of arrhythmia].
Pintér A; Zámolyi K; Székely A; Préda I
Orv Hetil; 1994 Jul; 135(28):1535-8. PubMed ID: 8058296
[TBL] [Abstract][Full Text] [Related]
26. [Circulatory arrest after combined intravenous drugs for the treatment of orthodromic circular tachycardia of Wolff-Parkinson-White syndrome].
Gómez-Barrado JJ; García-Rubira JC; Turégano Albarrán S; Pavón García M; Hidalgo Urbano R; Montes Ramírez JM; Cruz Fernández JM
Rev Esp Cardiol; 1997 Sep; 50(9):662-6. PubMed ID: 9380937
[TBL] [Abstract][Full Text] [Related]
27. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia.
Musto B; D'Onofrio A; Cavallaro C; Musto A
Circulation; 1988 Oct; 78(4):863-9. PubMed ID: 3168194
[TBL] [Abstract][Full Text] [Related]
28. [Electrophysiological testing of multiple antiarrhythmic drugs in patients with paroxysmal supraventricular tachycardia after chronic oral administration].
Nishino T
Hokkaido Igaku Zasshi; 1989 Nov; 64(6):738-48. PubMed ID: 2606448
[TBL] [Abstract][Full Text] [Related]
29. [The anti-arrhythmia effect and hemodynamic effects of Bonnecor in intravenous administration].
Volkmann H; Kühnert H; Dannberg G; Küch N; Büttner A
Z Gesamte Inn Med; 1989 Dec; 44(23):707-11. PubMed ID: 2629366
[TBL] [Abstract][Full Text] [Related]
30. [An analysis of clinical characteristics and acute treatment of supraventricular tachycardia in children from a multicenter study].
Li XM; Ge HY; Liu XQ; Shi L; Guo BJ; Li MT; Jiang H; Zhang Y; Liu HJ; Zheng XC; Li AJ; Zhang YY
Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):13-18. PubMed ID: 29342991
[No Abstract] [Full Text] [Related]
31. [Current treatment of supraventricular tachycardia: drug therapy].
Manz M; Lüderitz B
Z Gesamte Inn Med; 1993 Sep; 48(9):430-8. PubMed ID: 8212748
[TBL] [Abstract][Full Text] [Related]
32. [Our initial experience in using allapinin in patients with paroxysmal supraventricular tachycardias].
Golitsyn SP; Sokolov SF; Alikhanov GN; Malakhov VI; Smetnev AS
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(2):94-7. PubMed ID: 2604894
[TBL] [Abstract][Full Text] [Related]
33. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy.
Pritchett EL; McCarthy EA; Wilkinson WE
Ann Intern Med; 1991 Apr; 114(7):539-44. PubMed ID: 2001087
[TBL] [Abstract][Full Text] [Related]
34. [The treatment of arrhythmias in infants and children using propafenone].
Dressler F; Grävinghoff L; Grütte E; Jüngst BK; Liersch R; Nomayo H; Puls I; Rautenburg HW; Schmaltz A; Schumacher G
Monatsschr Kinderheilkd; 1985 Mar; 133(3):154-7. PubMed ID: 4010670
[TBL] [Abstract][Full Text] [Related]
35. Adenosine-induced cardiopulmonary arrest in a patient with paroxysmal supraventricular tachycardia--a response.
Jenkins NS; Knights M; Eickmann C; Payne M
Am J Emerg Med; 2010 May; 28(4):526; author reply 526-7. PubMed ID: 20466244
[No Abstract] [Full Text] [Related]
36. [Propafenone efficacy in preventing supraventricular tachycardia in childhood].
Bodegas A; Cabrera A; Sarrionaindía MJ; Idígoras G; Rumoroso JR; Pérez García P; Pastor E; Galdeano JM; Sota J; Barrenetxea JI
Rev Esp Cardiol; 1994 Feb; 47(2):86-91. PubMed ID: 8165353
[TBL] [Abstract][Full Text] [Related]
37. [Comparative study on the efficacy of disopyramide and propafenone in the prevention of the recurrence of ventricular tachycardia].
Palmieri M; Capucci A; Lombardi G; Naccarella F; Bomba E; Bracchetti D
G Ital Cardiol; 1984 May; 14(5):357-9. PubMed ID: 6468817
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy of intravenous Acehytisine Hydrochloride versus propafenone on terminating paroxysmal supraventricular tachycardia: a double-blinded, randomized multi-center study].
Gao X; Zhu J; Yang YM; Li JD; Yang ZM; Liu JH;
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Feb; 35(2):151-4. PubMed ID: 17445412
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing.
Furlanello F; Guarnerio M; Inama G; Vergara G; Del Greco M; Bertoldi A; Dallago M
Am J Cardiol; 1992 Aug; 70(5):19A-25A. PubMed ID: 1509994
[TBL] [Abstract][Full Text] [Related]
40. [Usefulness of transesophageal electrophysiological study during the ergometric test in the evaluation of supraventricular paroxysmal tachycardia occurring during exertion].
Delise P; D'Este D; Bonso A; Allibardi P; Raviele A; Di Pede F; Piccolo E
G Ital Cardiol; 1989 Dec; 19(12):1094-104. PubMed ID: 2576799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
